China · Delayed Price · Currency is CNY Nanjing Vazyme Biotech Company Description
Nanjing Vazyme Biotech Co., Ltd offers technology solutions for life science, biomedicine, and in vitro diagnostics.
The company offers reagents for molecular biology research, such as nucleic acid extraction, PCR, cloning/mutagenesis, nucleic acid electrophoresis, reverse transcription, real-time PCR (qPCR), genome editing, and cell biology/protein research; reagents for NGS library preparation, including automated liquid handling workstation, DNA sequencing, RNA sequencing, single cell-seq series, epigenetics series, beads series, quantification series, and capture series; reagents for molecular diagnosis comprising isothermal amplification reagents, PCR, reverse transcription, real-time PCR, one-step series, and animal detection; and reagents for bio-medicine, such as vaccine effectiveness evaluations and vaccine manufacture.
Nanjing Vazyme Biotech Co., Ltd was founded in 2012 and is based in Nanjing, China.
| Country | China |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,867 |
| CEO | Lin Cao |
Contact Details
Address: Building D2 Nanjing, 210033 China | |
| Phone | 86 25 8577 1179 |
| Website | vazyme.com |
Stock Details
| Ticker Symbol | 688105 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004ZK3 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Lin Cao | Chairman of the Board and GM |
| Lijun Zhang | Deputy GM and Director |
| Jin Huang | Board Secretary |
| Xiaoyu Xu | Deputy General Manager |
| Kai Shen | Accounting Supervisor |